OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies
Katsiaryna Marhelava, Marta Krawczyk, Małgorzata Firczuk, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1804-1804
Open Access | Times Cited: 8
Katsiaryna Marhelava, Marta Krawczyk, Małgorzata Firczuk, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1804-1804
Open Access | Times Cited: 8
Showing 8 citing articles:
Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells
Agnieszka Dąbkowska, Krzysztof Domka, Małgorzata Firczuk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Agnieszka Dąbkowska, Krzysztof Domka, Małgorzata Firczuk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Recent updates on allogeneic CAR-T cells in hematological malignancies
Shafieeh Mansoori, Ahmad Noei, Amirhosein Maali, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Shafieeh Mansoori, Ahmad Noei, Amirhosein Maali, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes
Nyerhovwo Obarorakpor, Deep Patel, Reni Boyarov, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Nyerhovwo Obarorakpor, Deep Patel, Reni Boyarov, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
Alejandrina Hernández-López, Alberto Olaya‐Vargas, Juan Carlos Bustamante‐Ogando, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 156-156
Open Access
Alejandrina Hernández-López, Alberto Olaya‐Vargas, Juan Carlos Bustamante‐Ogando, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 156-156
Open Access
Cuproptosis Related Gene DLD Associated with Poor Prognosis and Malignant Biological Characteristics in Lung Adenocarcinoma
Xinyang Li, Junshuai Rui, Zihan Yang, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 8, pp. 867-880
Closed Access | Times Cited: 3
Xinyang Li, Junshuai Rui, Zihan Yang, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 8, pp. 867-880
Closed Access | Times Cited: 3
Thrombotic Complications after Hematopoietic Stem Cell Transplantation and other Cellular Therapies
Paschalis Evangelidis, Eleni Gavriilaki, Dimitrios Α. Tsakiris
Thrombosis Update (2024) Vol. 16, pp. 100186-100186
Open Access | Times Cited: 2
Paschalis Evangelidis, Eleni Gavriilaki, Dimitrios Α. Tsakiris
Thrombosis Update (2024) Vol. 16, pp. 100186-100186
Open Access | Times Cited: 2
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of the ELM-1 study
Max S. Topp, Matthew J. Matasar, John N. Allan, et al.
Blood (2024)
Open Access | Times Cited: 2
Max S. Topp, Matthew J. Matasar, John N. Allan, et al.
Blood (2024)
Open Access | Times Cited: 2
Resistance to chimeric antigen receptor T cells (CAR-T)
Ramazan Kaşmer, Nihal Karakaş
Elsevier eBooks (2024), pp. 275-292
Closed Access
Ramazan Kaşmer, Nihal Karakaş
Elsevier eBooks (2024), pp. 275-292
Closed Access
